Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioRestorative Therapies (BRTX) Amortization - Intangibles (2016 - 2021)

BioRestorative Therapies (BRTX) has disclosed Amortization - Intangibles for 11 consecutive years, with $417160.0 as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Amortization - Intangibles fell 60.89% year-over-year to $417160.0, compared with a TTM value of $628738.0 through Mar 2021, down 84.26%, and an annual FY2020 reading of $1.3 million, down 65.18% over the prior year.
  • Amortization - Intangibles was $417160.0 for Q1 2021 at BioRestorative Therapies, up from $211578.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.5 million in Q3 2019 and bottomed at $84167.0 in Q2 2017.
  • Average Amortization - Intangibles over 5 years is $551680.5, with a median of $417160.0 recorded in 2021.
  • The sharpest move saw Amortization - Intangibles surged 1185.52% in 2018, then crashed 60.89% in 2021.
  • Year by year, Amortization - Intangibles stood at $242380.0 in 2017, then soared by 67.29% to $405475.0 in 2018, then increased by 10.78% to $449183.0 in 2019, then plummeted by 52.9% to $211578.0 in 2020, then surged by 97.17% to $417160.0 in 2021.
  • Business Quant data shows Amortization - Intangibles for BRTX at $417160.0 in Q1 2021, $211578.0 in Q4 2020, and $1.1 million in Q1 2020.